Uploaded on Aug 22, 2024
According to the latest research report by IMARC Group, The Vietnam pharmaceutical drug delivery market size is projected to exhibit a growth rate (CAGR) of 5.40% during 2024-2032. More Info:- https://www.imarcgroup.com/vietnam-pharmaceutical-drug-delivery-market
Vietnam Pharmaceutical Drug Delivery Market by Product Type, Distribution Channel, End User 2024-2032
Vietnam Pharmaceutical
Drug DeliveryMarket
Research and Forecast
Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved
About IMARC Group
In ternat ional Market Analys is Research and Consul t ing Group is a leading adv iser on management
s t rategy and market research wor ldwide. We par tner wi th c l ients in a l l regions and indust ry
vert ica ls to ident i fy thei r h ighest -value oppor tuni t ies, address thei r most cr i t ica l chal lenges, and
t ransform thei r bus inesses.
IMARC’s in format ion products inc lude major market , sc ient i f ic , economic and technological
developments for bus iness leaders in pharmaceut ica l , indust r ia l , and h igh technology
organizat ions. Market forecasts and indust ry analys is for b iotechnology, advanced mater ia ls ,
chemicals , food and beverage, t ravel and tour ism, nanotechnology and novel process ing methods
are at the top of the company’s exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight in to the dynamics o f companies and
markets wi th c lose cooperat ion at a l l levels of the c l ient organizat ion. This ensures that our c l ients
achieve unmatchable compet i t ive advantage, bui ld more pro f ic ient organizat ions, and secure
las t ing resul ts .
A c c o r d i n g t o t h e l a t e s t r e p o r t b y I M A R C G r o u p , t i t l e d " V i e t n a m P h a r m a c e u t i c a l D r u g
D e l i v e r y M a r k e t : I n d u s t r y T r e n d s , S h a r e , S i z e , G r o w t h , O p p o r t u n i t y a n d F o r e c a s t 2 0 2 4 -
2 0 3 2 , " t h e V i e t n a m p h a r m a c e u t i c a l d r u g d e l i v e r y m a r k e t s i z e i s p r o j e c t e d t o e x h i b i t a g r o w t h
r a t e ( C A G R ) o f 5 . 4 0 % d u r i n g 2 0 2 4 - 2 0 3 2 .
T h e V i e t n a m p h a r m a c e u t i c a l d r u g d e l i v e r y m a r k e t i s d r i v e n b y i n c r e a s i n g h e a l t h c a r e
Report i n v e s t m e n t s , r i s i n g p r e v a l e n c e o f c h r o n i c d i s e a s e s , a n d a d v a n c e m e n t s i n d r u g d e l i v e r y t e c h n o l o g i e s . K e y t r e n d s i n c l u d e a s h i f t t o w a r d s m o r e i n n o v a t i v e a n d p a t i e n t - f r i e n d l y d e l i v e r y
m e t h o d s s u c h a s t r a n s d e r m a l p a t c h e s , i n j e c t a b l e s , a n d i n h a l a t i o n s y s t e m s . T h e m a r k e t i s a l s o
Highlight and w i t n e s s i n g a g r o w i n g d e m a n d f o r b i o l o g i c s a n d b i o s i m i l a r s , n e c e s s i t a t i n g a d v a n c e d d e l i v e r y s o l u t i o n s .
A d d i t i o n a l l y , t h e g o v e r n m e n t ’ s f a v o r a b l e r e g u l a t o r y p o l i c i e s a n d i n i t i a t i v e s t o e n h a n c e l o c a l
Description p r o d u c t i o n c a p a b i l i t i e s a r e e n c o u r a g i n g m a r k e t e x p a n s i o n . T h e i n c r e a s i n g a d o p t i o n o f d i g i t a l h e a l t h t e c h n o l o g i e s , s u c h a s t e l e m e d i c i n e a n d e - p r e s c r i p t i o n s , f u r t h e r s u p p o r t s e f f i c i e n t d r u g
d e l i v e r y a n d p a t i e n t c o m p l i a n c e . A s a r e s u l t , b o t h m u l t i n a t i o n a l a n d l o c a l p h a r m a c e u t i c a l
c o m p a n i e s a r e i n v e s t i n g h e a v i l y i n r e s e a r c h a n d d e v e l o p m e n t t o s t a y c o m p e t i t i v e a n d c a p t u r e
m a r k e t s h a r e i n t h i s d y n a m i c e n v i r o n m e n t .
R e q u e s t f o r a P D F s a m p l e o f t h i s r e p o r t :
h t t p s : / / w w w . i m a r c g r o u p . c o m / v i e t n a m - p h a r m a c e u t i c a l - d r u g - d e l i v e r y - m a r k e t / r e q u e s t s a m p l e
Report Description
V ie t n a m P h a r m a c e u t i c a l D r u g D e l i v e r y M a r k e t T r e n d s :
T h e V i e tn a m p h a r m a c e u t i c a l d r u g d e l i v e r y m a r k e t i s e x p e r i e n c i n g r o b u s t g r o w t h d u e t o s e v e r a l k e y d r i v e r s a n d e m e r g i n g t r e n d s .
I n c r e a s i n g h e a l t h c a r e e x p e n d i t u r e , d r i v e n b y r i s i n g i n c o m e l e v e l s a n d g o v e r n m e n t i n v e s tm e n t , i s a p r i m a r y f a c to r p r o p e l l i n g
m a r k e t e x p a n s i o n . T h e p r e v a l e n c e o f c h r o n i c d i s e a s e s , s u c h a s d i a b e t e s a n d c a r d i o v a s c u l a r c o n d i t i o n s , i s a l s o e s c a l a t i n g ,
n e c e s s i t a t i n g a d v a n c e d a n d e f f i c i e n t d r u g d e l i v e r y s y s t e m s . I n n o v a t i o n s i n d r u g d e l i v e r y t e c h n o l o g i e s , i n c l u d i n g t r a n s d e r m a l
p a t c h e s , i n j e c t a b l e s , a n d i n h a l a t i o n s y s te m s , a r e g a i n i n g t r a c t i o n d u e t o t h e i r e n h a n c e d e f f i c a c y a n d p a t i e n t c o m p l i a n c e .
A d d i t i o n a l l y , t h e r e i s a g r o w i n g d e m a n d f o r b i o l o g i c s a n d b i o s i m i l a r s , w h i c h r e q u i r e s o p h i s t i c a t e d d e l i v e r y m e c h a n i s m s , f u r t h e r
s t i mu l a t i n g m a r k e t d e v e l o p m e n t . T h e V i e tn a m e s e g o v e r n m e n t ’ s f a v o r a b l e r e g u l a t o r y e n v i r o n m e n t a n d i n i t i a t i v e s t o b o l s t e r l o c a l
p h a r m a c e u t i c a l p r o d u c t i o n c a p a b i l i t i e s a r e e n c o u r a g i n g m a r k e t p l a y e r s t o e x p a n d t h e i r o p e r a t i o n s a n d i n v e s t i n r e s e a r c h a n d
d e v e l o p m e n t . T h e a d o p t i o n o f d i g i t a l h e a l t h t e c h n o l o g i e s , s u c h a s t e l e m e d i c i n e a n d e - p r e s c r i p t i o n s , i s a n o t h e r s i g n i f i c a n t t r e n d ,
f a c i l i t a t i n g s e a m l e s s d r u g d e l i v e r y a n d i m p r o v i n g p a t i e n t a d h e r e n c e t o t r e a t m e n t r e g i m e n s . F u r t h e r m o r e , i n c r e a s i n g
c o l l a b o r a t i o n s b e t w e e n m u l t i n a t i o n a l a n d l o c a l p h a r m a c e u t i c a l c o m p a n i e s a r e f o s te r i n g i n n o v a t i o n a n d e x p a n d i n g t h e m a r k e t
r e a c h . T h e f o c u s o n p e r s o n a l i z e d m e d i c i n e a n d t a r g e t e d d r u g d e l i v e r y i s a l s o s h a p i n g t h e m a r k e t , a s c o m p a n i e s s t r i v e t o o f f e r
t a i l o r e d s o l u t i o n s t h a t e n h a n c e t h e r a p e u t i c o u t c o m e s .
V ie w R e p o r t T O C , F i g u r e s a n d T a b l e s : h t t p s : / / w w w . i m a r c g r o u p . c o m / v i e t n a m - p h a r m a c e u t i c a l - d r u g - d e l i v e r y - m a r k e t
Route of Administration Insights:
• Oral Drug Del ivery
• In jectable Drug Del ivery
• Topical Drug Del ivery
• Ocular Drug Delivery
• Pulmonary Drug Del ivery
• Implantable Drug Del ivery
Report • Transmucosal Drug Del ivery
Segmentation • Nasal Drug Del ivery
Application Insights:
• Infect ious Diseases
• Cancer
• Cardiovascular Diseases
• Diabetes
• Respiratory Diseases
• Central Nervous System Disorders
• Autoimmune Diseases
• Others
End User Insights:
• Hospitals
Report • Ambulatory Surgery Centers
• Home Care Settings
Segmentation
• Diagnost ic Centers
• Others
Regional Insights:
• Northern Vietnam
• Central Vietnam
• Southern Vietnam
How has the Vietnam pharmaceutical drug delivery market
performed so far and how will it perform in the coming
years?
What has been the impact of COVID-19 on the Vietnam
pharmaceutical drug delivery market?
What is the breakup of the Vietnam pharmaceutical drug
delivery market on the basis of route of administration?
Key
What is the breakup of the Vietnam pharmaceutical drug
Questions delivery market on the basis of application?
Answered in What is the breakup of the Vietnam pharmaceutical drug delivery market on the basis of end user?
the Report What are the various stages in the value chain of the
Vietnam pharmaceutical drug delivery market?
What are the key driving factors and challenges in the
Vietnam pharmaceutical drug delivery?
What is the structure of the Vietnam pharmaceutical drug
delivery market and who are the key players?
What is the degree of competition in the Vietnam
pharmaceutical drug delivery market?
1 P r e f a c e
2 S c o p e a n d M e t h o d o l o g y
2 . 1 O b j e c t i v e s o f t h e S t u d y
2 . 2 S t a k e h o l d e r s
2 . 3 D a t a S o u r c e s
2 . 3 . 1 P r i m a r y S o u r c e s
2 . 3 . 2 S e c o n d a r y S o u r c e s
2 . 4 M a r k e t E s t i m a t i o n
Table of 2 . 4 . 1 B o t t o m - U p A p p r o a c h 2 . 4 . 2 T o p - D o w n A p p r o a c h
2 . 5 F o r e c a s t i n g M e t h o d o l o g y
3 E x e c u t i v e S u m m a r y
4 V i e t n a m P h a r m a c e u t i c a l D r u g D e l i v e r y M a r k e t - I n t r o d u c t i o n
Contents 4 . 1 O v e r v i e w 4 . 2 M a r k e t D y n a m i c s 4 . 3 I n d u s t r y T r e n d s
4 . 4 C o m p e t i t i v e I n t e l l i g e n c e
5 V i e t n a m P h a r m a c e u t i c a l D r u g D e l i v e r y M a r k e t L a n d s c a p e
5 . 1 H i s t o r i c a l a n d C u r r e n t M a r k e t T r e n d s ( 2 0 1 8 - 2 0 2 3 )
5 . 2 M a r k e t F o r e c a s t ( 2 0 2 4 - 2 0 3 2 )
6 V i e t n a m P h a r m a c e u t i c a l D r u g D e l i v e r y M a r k e t - B r e a k u p b y R o u t e o f
A d m i n i s t r a t i o n
6 . 1 O r a l D r u g D e l i v e r y
6 . 1 . 1 O v e r v i e w
6 . 1 . 2 H i s t o r i c a l a n d C u r r e n t M a r k e t T r e n d s ( 2 0 1 8 - 2 0 2 3 )
6 . 1 . 3 M a r k e t F o r e c a s t ( 2 0 2 4 - 2 0 3 2 )
6 . 2 I n j e c t a b l e D r u g D e l i v e r y
6 . 2 . 1 O v e r v i e w
6 . 2 . 2 H i s t o r i c a l a n d C u r r e n t M a r k e t T r e n d s ( 2 0 1 8 - 2 0 2 3 )
6 . 2 . 3 M a r k e t F o r e c a s t ( 2 0 2 4 - 2 0 3 2 )
6 . 3 T o p i c a l D r u g D e l i v e r y
6 . 3 . 1 O v e r v i e w
6 . 3 . 2 H i s t o r i c a l a n d C u r r e n t M a r k e t T r e n d s ( 2 0 1 8 - 2 0 2 3 )
6 . 3 . 3 M a r k e t F o r e c a s t ( 2 0 2 4 - 2 0 3 2 )
6 . 4 O c u l a r D r u g D e l i v e r y
6 . 4 . 1 O v e r v i e w
6 . 4 . 2 H i s t o r i c a l a n d C u r r e n t M a r k e t T r e n d s ( 2 0 1 8 - 2 0 2 3 )
6 . 4 . 3 M a r k e t F o r e c a s t ( 2 0 2 4 - 2 0 3 2 )
6 . 5 P u l m o n a r y D r u g D e l i v e r y
6 . 5 . 1 O v e r v i e w
6 . 5 . 2 H i s t o r i c a l a n d C u r r e n t M a r k e t T r e n d s ( 2 0 1 8 - 2 0 2 3 )
Table of 6 . 5 . 3 M a r k e t F o r e c a s t ( 2 0 2 4 - 2 0 3 2 ) 6 . 6 I m p l a n t a b l e D r u g D e l i v e r y
6 . 6 . 1 O v e r v i e w
6 . 6 . 2 H i s t o r i c a l a n d C u r r e n t M a r k e t T r e n d s ( 2 0 1 8 - 2 0 2 3 )
Contents 6 . 6 . 3 M a r k e t F o r e c a s t ( 2 0 2 4 - 2 0 3 2 ) 6 . 7 T r a n s m u c o s a l D r u g D e l i v e r y
6 . 7 . 1 O v e r v i e w
6 . 7 . 2 H i s t o r i c a l a n d C u r r e n t M a r k e t T r e n d s ( 2 0 1 8 - 2 0 2 3 )
6 . 7 . 3 M a r k e t F o r e c a s t ( 2 0 2 4 - 2 0 3 2 )
6 . 8 N a s a l D r u g D e l i v e r y
6 . 8 . 1 O v e r v i e w
6 . 8 . 2 H i s t o r i c a l a n d C u r r e n t M a r k e t T r e n d s ( 2 0 1 8 - 2 0 2 3 )
6 . 8 . 3 M a r k e t F o r e c a s t ( 2 0 2 4 - 2 0 3 2 )
7 V i e t n a m P h a r m a c e u t i c a l D r u g D e l i v e r y M a r k e t - B r e a k u p b y
A p p l i c a t i o n
7 . 1 I n f e c t i o u s D i s e a s e s
7 . 1 . 1 O v e r v i e w
7 . 1 . 2 H i s t o r i c a l a n d C u r r e n t M a r k e t T r e n d s ( 2 0 1 8 - 2 0 2 3 )
7 . 1 . 3 M a r k e t F o r e c a s t ( 2 0 2 4 - 2 0 3 2 )
F o r m o r e i n f o r m a t i o n , v i s i t :
h t t p s : / / w w w. im a rcg ro u p . co m / v ie t n a m - p h a rm a c eu t i c a l - d r u g - de l i v
e r y - m a r ke t / t o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024 IMARC Al l R ights Reserved
Th is Pub l i ca t ion and a l l i t ’ s con ten ts un less o therw ise men t i oned a re copy r i gh ted in the name o f
I n t e rna t i ona l Marke t Ana lys i s Research and Consu l t ing ( IMARC) . No pa r t o f t h i s pub l i ca t ion may be
rep roduced , repackaged , red i s t r i bu ted o r res o ld i n who le o r i n any pa r t . The pub l i ca t ion may a l so
no t be used i n any f o rm o r by and means g raph i c e lec t ron ic o r mechan ic a l , i nc lud ing pho tocopy ing ,
reco rd ing , t ap ing o r by i n fo rmat i on s to rage o r re t r ieva l , o r by any o the r f o rm, w i t hou t the exp ress
c ons en t o f I n t e rna t iona l Marke t Ana lys i s Research and Consu l t i ng ( IMARC) .
Disc la imer : Al l con ten ts and da ta o f t h i s pub l i c a t i on , i nc lud ing fo recas t s , da ta ana lys i s and op in ion
have been based on in f o rmat ion and sources be l ieved to be accu ra te and re l iab le a t t he t ime o f
pub l i sh ing . In t e rna t i ona l Ma rke t Ana l ys is Research and Consu l t ing makes no rep resen ta t ion o f
war ran t y o f any k ind as to t he acc u racy o r comp le teness o f any I n fo rmat i on p rov ided . IMARC
accep ts no l i ab i l i t y wha tsoever f o r any los s o r damage resu l t i ng f rom op in ion , e r ro rs o r
i naccu rac ies i f any f ound th is pub l i ca t ion .
IMARC, IMARC Group and G loba l Therapy I ns igh t Ser i es a re reg is t e red t rademarks o f I n te rna t iona l
Marke t Ana lys i s Research and Consu l t ing . A l l o the r t rademarks used i n th i s pub l i ca t i on a re
reg i s te red t rademarks o f t he i r r espec t i ve compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us:
Comments